Article

bizjournals.com on 2020-09-29 18:49

Main Line's Aclipse Therapeutics lands $720K from Australia research firm to advance ALS therapy

Related news

CSL lands world-first gene therapy with $5.3m haemophilia treatment Sydney Morning Herald
Australia , United States , Australia
Jennifer Doudna’s Scribe Therapeutics lands a $100M Series B to advance CRISPR technology bizjournals.com
UMass Medical School gene therapy model may advance treatment of deadly pregnancy complication telegram.com
United States , Australia
Gene therapy mends optic nerves in promising advance for treating glaucoma newatlas.com
Australia
Main Line biopharma firm behind Covid-19 therapy raises $30M to advance product line bizjournals.com
Pennsylvania Main Line
Cell therapy developer WindMIL Therapeutics raises $2.3M bizjournals.com
TNami Therapeutics Startup Pursues Promising Drug Therapy today.uconn.edu
Chapel Hill
Non-union couple $720k compo: MUA considers appeal watoday.com.au
Australia , Perth
Main Line's Yangming cleared to re-open Philly.com
The Bryn , Radnor , Yangming , Pennsylvania Main Line
Main Line's Yangming set to reopen Philly.com
Radnor , Yangming , Pennsylvania Main Line
FDA approves Spark Therapeutics' gene therapy treatment; pricing questions remain bizjournals.com
United Therapeutics gets disappointing news on cancer therapy bizjournals.com
Tmunity Therapeutics expands cell therapy partnership with University of Pennsylvania bizjournals.com
United Therapeutics gets another FDA approval for pulmonary hypertension therapy bizjournals.com
Spark Therapeutics sues gene therapy rival Bluebird Bio bizjournals.com
Bluebird bio sued by gene therapy rival Spark Therapeutics bizjournals.com
European approval of Spark Therapeutics' gene therapy triggers $25M payment bizjournals.com
Adaptive Phage Therapeutics raises $7M for pathogen therapy thedailyrecord.com